Literature DB >> 31302946

Diagnosing Kikuchi's disease on fine needle aspiration biopsy.

Miao Wang1, Xiaomeng Yu1, Yan Yang1.   

Abstract

OBJECTIVE: To investigate the diagnostic utility of fine needle aspiration (FNA) smear, cell block (CB), flow cytometry (FC) and tuberculosis polymerase chain reaction (Tb-PCR) analysis for Kikuchi's disease (KD).
METHODS: A total of 173 FNA biopsy samples were collected using a Youyi aspirator. KD was diagnosed by FNA smear, with or without, CB, FC and Tb-PCR.
RESULTS: Out of 173 patients, 131 (75.7%) were female and 126 (72.8%) aged 21-40 years. Of these, 171 patients (98.8%) presented with painful enlarged cervical lymph nodes. All cytological samples identified intracellular apoptotic debris embedded in the cytoplasm of crescentic and phagocytic macrophages. In 24 cell-blocks (CBs), clusters of CD123 positive plasmacytoid monocytes were observed in KD. FC and CBs showed non-specific lymphoid hyperplasia in nine cases with suspicious lymphoma. Tb-PCR was negative in five cases with suspicion of tuberculosis.
CONCLUSIONS: In summary, FNA biopsy is a fast, reliable, and relatively inexpensive diagnosis tool for KD. CB preparation is an important adjunct method for the diagnosis of KD.
© 2019 John Wiley & Sons Ltd.

Entities:  

Keywords:  Kikuchi's disease; cell block; fine needle aspiration

Mesh:

Year:  2019        PMID: 31302946     DOI: 10.1111/cyt.12754

Source DB:  PubMed          Journal:  Cytopathology        ISSN: 0956-5507            Impact factor:   2.073


  2 in total

1.  Transcriptomic analysis reveal the responses of dendritic cells to VDBP.

Authors:  Biwei Cao; Tao Wen; Meng Wei; Yuan Xiong; Wan Liu; Li Zhu; Jing Zhou
Journal:  Genes Genomics       Date:  2022-03-12       Impact factor: 2.164

2.  Comparison of transbronchial needle aspiration with and without ultrasound guidance for diagnosing benign lymph node adenopathy.

Authors:  Hui Shen; Lingyun Lou; Ting Chen; Yi Zou; Bin Wang; Zhihao Xu; Qin Ye; Huahao Shen; Wen Li; Yang Xia
Journal:  Diagn Pathol       Date:  2020-04-15       Impact factor: 2.644

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.